ReviewComputational and structural biotechnology journal2025
Drug response in the era of precision medicine: A methodological review.
Review in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Sex Differences in Psychotropic Drug Exposure and Safety: A Systematic Review Toward Personalized Dosing Strategies.Journal of personalized medicine · 2026Review
- Artemis: Harnessing Knowledge Graphs for Next-Generation Drug Target Prioritization.Computational and structural biotechnology journal · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing availability of structured data types, including molecular and pharmacological data, along with unstructured data types such as medical imaging data, has enabled the development of statistical, machine learning (ML), and deep learning (DL) approaches for drug response prediction. These computational methods are integral to precision medicine, leveraging data-driven techniques to predict patient-specific treatment outcomes. This review provides a systematic overview of existing methodologies for drug response prediction, focusing on input data structures, response variable definitions, and data types utilized. In contrast to previous reviews that focus on specific therapies or computational approaches, we present a unified classification framework based on data-response relationships, including single data type with a response vector, single data type with a response matrix, and multiple data types with a response. By using this structure, we can compare statistical and ML-based models across different diseases and data types. Finally, we discuss evaluation strategies, highlight emerging methodological trends, and outline key challenges and future opportunities to advance drug response prediction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.